aguillerm, Author at Enterosys

Enterosys participates in Biofit 2022 in Strasbourg

BioFIT is the place where academia-industry collaborations get started.

Preserve the bioactive factors of breast milk

Human breast milk donated to human milk banks is the sole diet for preterm infants when maternal BM is not available. Pasteurization of donated breast milk is an essential step to inactivate pathogens to ensure microbial safety for preterm babies. The study of intestinal motility can be used to optimize pasteurization processes.

Enterosys participates in the closing meeting of the Thinkgut project

On April 26, the 4th Project Progress Meeting of the Thinkgut project was held

Enterosys welcomes its new CEO

a new CEO and a new vision

Enterosys participates in AFSSI Connexions in Lyon

The annual preclinical research meeting

Enterosys participates in the opening meeting of the LEARN project

LEARN project: Nutritional models of NASH, biomarkers and mechanisms

Enterosys CSO elected to the AFSSI Board of Directors.

Enterosys participates in strategic discussions on future challenges for preclinical CROs

Enterosys becomes a member of the Pharmabiotic Research Institute (PRI)

Our CRO is part of the biotech ecosystem developing microbiome-based medicinal products

Research

Categorie

Functional ingredients: from plausibility to proof

The functional food market is no longer a niche. The global functional foods market was estimated at $332 billion in 2024 and is expected to grow to $638 billion by 2034, at a CAGR of 6.9%. In North America alone, more than 65% of consumers reported in 2024 actively...

Aging impairs the gut: microbiota, barrier signals and systemic alterations

We often talk about aging in terms of mitochondria, senescent cells, or epigenetics. But there’s a system we still underestimate, one that quietly shapes inflammation, resilience, and even how our organs “age together”: the gut. In fact, scientific frameworks now...

Gut–Skin axis 2.0: why 75 % of gut disorders break out on your skin

Quick recap : what we covered last time In my first newsletter we introduced the gut–skin axis: a two-way biochemical hotline in which intestinal dysbiosis, “leaky-gut” endotoxins and microbially produced metabolites ignite cytokine storms that thin the epidermal...

Gut–skin axis: a scientific rationale for dermatological disorders

In recent years, dermatological research has increasingly turned inward, toward the gut! The concept of the gut–skin axis has gained considerable traction, supported by robust data linking intestinal health and microbial balance to the onset and progression of...

Gut motility: the hidden role of the enteric nervous system

TAKE HOME MESSAGES : The ENS orchestrates gut motility through a complex balance of neural circuits and neurotransmitters. Disruptions in gut motility can trigger systemic metabolic imbalances, contributing to hyperglycemia and insulin resistance. ENS dysfunction is...